COST-EFFECTIVENESS OF DRUG ABUSE TREATMENT FOR PRIMARY PREVENTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME: EPIDEMIOLOGIC CONSIDERATIONS. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| التنسيق: | فصل الكتاب |
| اللغة: | الإنجليزية |
| منشور في: |
ROCKVILLE,MD (USA)
NATIONAL INSTITUTE ON DRUG ABUSE
1993
|
| الموضوعات: | |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة: COST-EFFECTIVENESS OF DRUG ABUSE TREATMENT FOR PRIMARY PREVENTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME: EPIDEMIOLOGIC CONSIDERATIONS. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT
- EVALUATING THE COST-EFFECTIVENESS OF DRUG ABUSE TREATMENT SERVICES. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT
- COST-EFFECTIVENESS OF DRUG ABUSE TREATMENT: RELEVANT ISSUES AND ALTERNATIVE LONGITUDINAL MODELING APPROACHES. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT
- ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT. NIDA RESEARCH MONOGRAPH SERIES Nº 113
- FINANCING TREATMENT FOR SUBSTANCE ABUSE. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT
- POLICY-RELEVANT RESEARCH ON DRUG TREATMENT. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT
- FORECASTING THE COST OF DRUG ABUSE TREATMENT COVERAGE IN PRIVATE HEALTH INSURANCE. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT